Magnesium transporters and divalent cation channels (Mg2+ Transporters)

Magnesium ions and other transported divalent cations represent a broad category of physiological substrates managed by a diverse set of specialized transport proteins and ion channels. These include the Transient Receptor Potential Melastatin members (TRPM6 and TRPM7), the SLC41 family of magnesium transporters, and the Magnesium Transporter 1 (MagT1), which collectively maintain magnesium homeostasis essential for over 300 enzymatic reactions, ATP stability, and DNA synthesis (Source: UniProt, P57071; PubMed: 25748225). Magnesium acts as a natural calcium antagonist and is critical for stabilizing excitable membranes in cardiac and neuronal tissues. Dysregulation of these transport systems is linked to various pathologies, including hereditary hypomagnesemia, cardiovascular arrhythmias, and metabolic syndrome (Source: StatPearls, NBK500003). Pharmacological intervention typically involves direct ion supplementation to treat deficiencies or managing the off-target effects of drugs like proton pump inhibitors and calcineurin inhibitors that interfere with these transport mechanisms (Source: NIH, Magnesium Fact Sheet).

Other names

Magnesium ion transportersDivalent metal ion transportersMg2+ transport systemDivalent cation transport protein

Drugs typically act as exogenous ion replacements to restore physiological levels, or as inhibitors/modulators of the transport proteins (e.g., diuretics affecting renal reabsorption or immunosuppressants causing secondary transport inhibition).